Negative cooperativity in H2 relaxin binding to a dimeric relaxin family peptide receptor 1☆
Introduction
Relaxin was first isolated in 1926 by Frederik Hisaw (reviewed in Ziel and Sawin, 2000). After a period of neglect, recent research has given many new insights about the hormones of this peptide family, their receptors and the importance of relaxin family peptide receptors as new drug targets (reviewed in Bathgate et al., 2005b, Ivell et al., 2005, Ivell and Bathgate, 2002, Dschietzig et al., 2006, Van Der Westhuizen et al., 2007).
Relaxin belongs to the insulin/relaxin superfamily of peptides which in humans comprises insulin, IGF-I and IGF-II, relaxins (H1, H2 and H3), and INSL3–INSL6. H2 relaxin (which we will term relaxin from now on) was traditionally associated with pregnancy. It is synthesized in the corpora lutea of ovaries during pregnancy. Its physiological role appears to be species-specific (see Sherwood, 2004 and Dschietzig et al., 2006, for recent reviews). In nonhuman mammals, relaxin is highest in the days before birth (Hudson et al., 1983). Its major biological effect is to remodel the mammalian reproductive tract to facilitate the birth process (loosening of the pubic symphysis and relaxation of the cervix) (Ivell, 2002, Porter, 1972). Besides, relaxin also promotes the development of the mammary organs, thus enabling normal lactational performance. During pregnancy, relaxin inhibits uterine contractility and promotes the osmoregulatory changes of pregnancy in rats. In males, relaxin has been shown to be expressed in almost all parts of the male reproductive tract, with high levels in testis and vas deferens (Filonzi et al., 2007). In humans, relaxin is at its highest in the first trimester of pregnancy. Its involvement in decidualization and in preterm premature rupture of the fetal membranes has been extensively studied by Bryant-Greenwood's group (see Bryant-Greenwood et al., 2005, for recent review). Relaxin has also a number of nonreproductive actions (see Dschietzig et al., 2006, for recent review).
Relaxin-3 is not involved in reproduction but is believed to be a putative neuropeptide involved in appetite regulation (McGowan et al., 2005). Relaxin-3 is most likely the ancestor to the entire relaxin peptide family (Wilkinson et al., 2005). INSL3, expressed in the testis and ovary, and its receptor RXFP2 were shown to initiate oocyte maturation and to suppress male germ cell apoptosis. The administration of an RXFP2 antagonist resulted in an increased germ cell apoptosis, suggesting that INSL3 antagonists may have potential as novel contraceptive agents (Del Borgo et al., 2006). It has been proposed that INSL3 plays an important role in spermatogenesis as well as differentiation and maintenance of the male phenotype (reviewed in Ivell and Bathgate, 2002). In females, INSL3 has a role in the regulation of the oestrus cycle and possibly in follicular development, explaining the impaired fertility in INSL3 knockout mice (Nef and Parada, 1999). The functions of H1 relaxin and INSL4 to INSL6 remain unknown (Wilkinson et al., 2005).
Relaxin binds and activates RXFP1, which is assumed to be the cognate receptor of relaxin. It is also able to bind with lower affinity to RXFP2, although the significance of this binding in vivo is unknown (Svendsen et al., 2008). RXFP1 and RXFP2 belong to Type C LGRs (leucine-rich repeat-containing G-protein-coupled receptor) of the class A subtype of GPCRs (rhodopsin-like family). They are unique because they have N-terminal domains which have homology to the LDLa modules that constitute the ligand binding repeats found in the LDL receptor family (Scott et al., 2006). The ectodomain of RXFP1 and RXFP2 functions as the primary ligand-binding domain. Ligand binding leads to the activation of adenyl cyclase and the protein kinase A-dependent pathway in many target tissues (Bathgate et al., 2005a, Hsu et al., 2002).
There is increasing evidence that GPCRs are allosteric proteins (Springael et al., 2007). Allosterism is a property displayed by many oligomeric proteins. The binding of a molecule at one site induces a change in the binding properties of another site of the protein. In the case of negative cooperativity, the receptor sites do not have a fixed affinity, rather, the affinity of the receptors decreases as a function of the occupancy of the receptor population and is usually measured by ligand-accelerated tracer dissociation in an infinite dilution procedure (De Meyts et al., 1973). Negative cooperativity is a mechanism that increases the range of the effective concentrations of the ligands.
After negative cooperativity in ligand binding was demonstrated for the insulin receptor in the early seventies (De Meyts et al., 1973), it was also demonstrated for the β2-adrenergic (Limbird et al., 1975) and TSH receptors (De Meyts, 1976), later found to be GPCRs. The homodimerization of the β2-adrenergic receptor and the TSH receptor was subsequently established (Graves et al., 1996, Angers et al., 2000, Latif et al., 2001, Rapoport and McLachlan, 2007), and the link between homo- and heterodimerization and the existence of negative cooperativity in LGR receptors including the TSH receptor was recently demonstrated, confirming the earlier TSH receptor observations (Urizar et al., 2005). Similar findings with chemokine receptors suggest that dimerization and negative cooperativity may be the rule rather than the exception among GPCRs (Springael et al., 2005). The dimerization of receptors has been shown to have many physiological roles such as receptor maturation, regulation of ligand binding, G-protein selectivity, or internalization (reviewed in Terrillon and Bouvier, 2004), and therefore it is of importance to investigate this mechanism in any particular receptor/ligand system. The relevance of dimerization and allosterism for the physiological properties of GPCRs, and implications for drug design, has been recently reviewed (see Springael et al., 2007). However, no data were available on the RXFP group of receptors involved in human reproduction until we recently showed that INSL3 binding to RXFP2 shows negative cooperativity, and that RXFP2 forms homodimers, as well as heterodimers with RXFP1 (Svendsen et al., 2008).
In this study we investigated whether negative cooperativity and dimerization are general properties of the LGR class of GPCRs by investigating whether H2 relaxin binding to RXFP1 displays properties similar to those of INSL3 binding to RXFP2, and whether RXFP1 forms homodimers. Furthermore we have investigated in detail the binding kinetics of H2 relaxin binding to RXFP1. Earlier studies focused solely on the binding affinity while here we have also investigated in detail kinetic properties such as association/dissociation time, temperature-/pH dependence of association and dissociation, and dose–response curves for negative cooperativity.
Section snippets
Chemicals and reagents
Cell culture reagents, FBS, transfection lipids and antibiotics were purchased from Invitrogen, Copenhagen, DK. Chemicals were purchased from Sigma, Copenhagen, DK. Recombinant H2 relaxin was kindly provided by BAS Medical, and synthetic H3 relaxin and INSL3 were provided by JD Wade.
Cell culture
HEK293 cells obtained from the European Collection of Animal Cell Cultures (Salisbury, UK) and HEK293T cells stably transfected with RXFP1 (HEK293T-RXFP1) (Bathgate et al., 2006), were cultured in RPMI 1640 with 10%
Cell concentration dependence of H2 relaxin binding to HEK293T-RXFP1 cells
H2 relaxin was labeled with 125I at position TyrA3 as has been described before (Palejwala et al., 1998). The labeling gave two batches (A and B) whereof batch A was oxidized at unknown position, most likely outside the binding cassette. Both batches showed similar affinity and could be used for the experiments (Fig. 1). The binding of the tracer was a linear function of the cell concentration. As shown in Fig. 1 there is a linear increase in the Bound/Free of 125I-H2 relaxin over a 30-fold
Acknowledgements
The Receptor Systems Biology Laboratory and the Hagedorn Research Institute are independent basic research components of Novo Nordisk A/S.
Funding: Australian National Health and Medical Research Council (NHMRC) (30012, 350245 to RADB and JDW).
Slovenian Research Agency (Slovenian-Danish collaboration grant BI-DK/07-09-02 to MV).
References (65)
The insulin receptor: a prototype for dimeric, allosteric membrane receptors?
Trends Biochem Sci.
(2008)- et al.
Site–site interactions among insulin receptors. Characterization of the negative cooperativity
J. Biol. Chem.
(1976) - et al.
Insulin interactions with its receptors, experimental evidence for negative cooperativity
Biochem. Biophys. Res. Commun.
(1973) - et al.
Analogs of insulin-like peptide 3 (INSL3) B-chain are LGR8 antagonists in vitro and in vivo
J. Biol. Chem.
(2006) - et al.
Relaxin—a pleiotropic hormone and its emerging role for experimental and clinical therapeutics
Pharmacol. Ther.
(2006) - et al.
Characteristics of the human lymphocyte insulin receptor
J. Biol. Chem.
(1973) - et al.
Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses
J. Biol. Chem.
(2007) - et al.
Oligomerization of the human thyrotropin receptor. Fluorescent protein-tagged hTSHR reveals post-translational complexes
J. Biol. Chem.
(2001) - et al.
Two defective heterozygous luteinizing hormone receptors can rescue hormone action
J. Biol. Chem.
(2002) - et al.
Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes
J. Biol. Chem.
(2003)
Beta adrenergic receptors: evidence for negative cooperativity
Biochem. Biophys. Res. Commun.
Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules
J. Biol. Chem.
Allosteric properties of G protein-coupled receptor oligomers
Pharmacol. Ther.
Dimerization of chemokine receptors and its functional consequences
Cytokine Growth Fact. Res.
H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2
J. Biol. Chem.
Development of a BRET2 screening assay using beta-arrestin 2 mutants
J. Biomol. Screen.
The pH dependence of insulin binding. A quantitative study
J. Biol. Chem.
Receptor–receptor interactions, receptor mosaics, and basic principles of molecular network organization—possible implications for drug development
J. Mol. Neurosci.
Detection of beta2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET)
Proc. Natl. Acad. Sci. U.S.A.
Physiology and molecular biology of the relaxin peptide family
Receptors for relaxin family peptides
Ann. N.Y. Acad. Sci.
Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo
Biochemistry
Human decidual relaxin and preterm birth
Ann. N.Y. Acad. Sci
High-resolution crystal structure of an engineered human beta(2)-adrenergic G protein-coupled receptor
Science
Cooperative properties of hormone receptors in cell membranes
J. Supramol. Struct.
Structural biology of insulin and IGF1 receptors: implications for drug design
Nat. Rev. Drug Discov.
Structure of human follicle-stimulating hormone in complex with its receptor
Nature
Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling
Pharmacol. Rev.
Relaxin family peptide receptors RXFP1 and RXFP2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat
Reprod. Biol. Endocrin.
Pathways of internalization of the hCG-LH receptor immunoelecton microscopic studies in Leydig cells and transfected L cells
J. Cell. Biol.
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Nature
Multimeric complex formation by the thyrotropin receptor in solubilized thyroid membranes
Endocrinology
Cited by (41)
Relaxin abrogates genomic remodeling of the aged heart
2021, Vitamins and HormonesCitation Excerpt :As many as 29 naturally occurring alternative splicing variants of RXFP1 have been identified (Kern, Hubbard, Amano, & Bryant-Greenwood, 2008; Scott et al., 2006), and some of these have been reported to interfere with RLX2-dependent cAMP signaling, either by reducing RLX binding or by interfering with downstream signaling (Scott et al., 2006). Furthermore, there is substantial evidence that indicates that RXFP1 forms receptor homodimers with itself, and heterodimers with some of the alternative RXFP1 splice products or other GPCRs (Chen et al., 2020; Chow et al., 2014, 2019; Svendsen et al., 2008, 2008). These complexes, in particular the heterodimers, give rise to intricate ligand binding behaviors, including negative cooperativity (Svendsen, Zalesko, et al., 2008).
Pancreatic Hormones
2020, Hormonal Signaling in Biology and Medicine: Comprehensive Modern EndocrinologyPancreatic Hormones
2019, Hormonal Signaling in Biology and Medicine: Comprehensive Modern EndocrinologyFunctional characterization of β<inf>2</inf>-adrenergic and insulin receptor heteromers
2019, NeuropharmacologyCitation Excerpt :During the 1970s, early kinetic demonstration of negative cooperativity, for which dimerization is a prerequisite, suggested oligomeric nature of membrane receptors, before they were known to be RTKs or 7TMRs (De Meyts, 1976; de Meyts et al., 1973; Frazier et al., 1974; Limbird et al., 1975). This concept was later supported by ample contemporary demonstration of negative cooperativity/dimerization in RTKs and 7TMRs (Alvarado et al., 2010; Christopoulos and Kenakin, 2002; Christopoulos et al., 1997; De Meyts et al., 2009; Gao et al., 2009; Latif et al., 2001; Macdonald and Pike, 2008; Pizard et al., 1998; Roed et al., 2012; Springael et al., 2006; Svendsen et al., 2008a, 2008b; Urizar et al., 2005). Functional implications of β2AR oligomerization have been extensively studied and its appears that β2AR oligomers are functional form of the receptor (reviewed in (Cotecchia et al., 2012)).
Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis
2019, iScienceCitation Excerpt :In addition, saturation binding experiments in HEK293 cells lacking Gαs, the primary G protein to which RXFP1 is coupled in HEK cells, did not show any significant difference in relaxin binding affinity, and previous studies have found no change in relaxin binding affinity in membrane preparations in the presence of the non-hydrolysable GTP analogs, Gpp(NH)p and GTPγS (Scott et al., 2006). Another alternative explanation for a two-phase TamRLX dissociation relates to possible homodimerization of RXFP1 (Svendsen et al., 2008), or differing localization of the receptor within the cell (for example, intracellular pools of receptor, receptor clustering within different membrane microdomains, or receptor internalization), providing a framework by which two relaxin-binding sites might exist with two slightly different affinities. These explanations also fall short for three reasons.
Antifibrotic Actions of Serelaxin - New Roles for an Old Player
2016, Trends in Pharmacological Sciences
- ☆
These results were presented at ENDO 2007, The Endocrine Society's 89th annual meeting, June 2007, Toronto, Canada: Larsen, J.N., Zalesko, A., Svendsen, A.M., Vrecl, M., Heding, A., Bathgate, R.A.D., De Meyts P., Kinetics of human H2 relaxin binding to the relaxin family peptide 1 receptor RXFP1: evidence for negative cooperativity and receptor dimerization (Abstract no. P4-297).